BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26745654)

  • 1. The Complex Role of Anticoagulation in Cirrhosis: An Updated Review of Where We Are and Where We Are Going.
    Khoury T; Ayman AR; Cohen J; Daher S; Shmuel C; Mizrahi M
    Digestion; 2016; 93(2):149-59. PubMed ID: 26745654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suboptimal use of pharmacological venous thromboembolism prophylaxis in cirrhotic patients.
    Yang LS; Alukaidey S; Croucher K; Dowling D
    Intern Med J; 2018 Sep; 48(9):1056-1063. PubMed ID: 29468795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of hemorrhage in patients with chronic liver disease and coagulopathy receiving pharmacologic venous thromboembolism prophylaxis.
    Reichert JA; Hlavinka PF; Stolzfus JC
    Pharmacotherapy; 2014 Oct; 34(10):1043-9. PubMed ID: 25052037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature.
    Tufano A; Guida A; Di Minno MN; Prisco D; Cerbone AM; Di Minno G
    Semin Thromb Hemost; 2011 Apr; 37(3):267-74. PubMed ID: 21455860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic prophylaxis against venous thromboembolism in hospitalized patients with cirrhosis and associated coagulopathies.
    Koliscak L; Maynor L
    Am J Health Syst Pharm; 2012 Apr; 69(8):658-63. PubMed ID: 22472867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? Yes.
    Basili S; Raparelli V; Violi F
    Eur J Intern Med; 2010 Apr; 21(2):62-4. PubMed ID: 20206871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant therapy for splanchnic vein thrombosis: recent updates for patients with liver cirrhosis.
    Caiano LM; Riva N; Ageno W
    Expert Rev Hematol; 2023 Feb; 16(2):121-129. PubMed ID: 36820873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should patients with chronic liver disease receive venous thromboembolism prophylaxis?
    Dang JD; Davis LE
    JAAPA; 2015 Jun; 28(6):27-8, 30. PubMed ID: 25989432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism in cirrhosis: a review of the literature.
    Buresi M; Hull R; Coffin CS
    Can J Gastroenterol; 2012 Dec; 26(12):905-8. PubMed ID: 23248793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal endoscopy in the cirrhotic patient.
    Horsley-Silva JL; Vargas HE
    Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):1005-13. PubMed ID: 25967459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of venous thromboembolism in patients with chronic liver disease and the utility of venous thromboembolism prophylaxis.
    Pincus KJ; Tata AL; Watson K
    Ann Pharmacother; 2012 Jun; 46(6):873-8. PubMed ID: 22570429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation Therapy in Patients with Liver Cirrhosis is Associated With an Increased Risk of Variceal Hemorrhage.
    Sasso R; Rockey DC
    Am J Med; 2019 Jun; 132(6):758-766. PubMed ID: 30660572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices.
    Albillos A; Calleja JL
    Gastrointest Endosc; 1998 Feb; 47(2):202-4. PubMed ID: 9512295
    [No Abstract]   [Full Text] [Related]  

  • 14. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
    Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
    J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splanchnic vein thrombosis and variceal rebleeding in patients with cirrhosis.
    Amitrano L; Guardascione MA; Scaglione M; Menchise A; Martino R; Manguso F; Lanza AG; Lampasi F
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1381-5. PubMed ID: 23114742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Liver cirrhosis--procoagulant stasis].
    Prelipcean CC; Fierbinteanu-Braticevici C; Drug VL; Lăcătuşu C; Mihai B; Mihai C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):678-85. PubMed ID: 22046771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? No.
    Tripodi A
    Eur J Intern Med; 2010 Apr; 21(2):65-9. PubMed ID: 20206872
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anticoagulation in Patients with Liver Cirrhosis].
    Cheong JY
    Korean J Gastroenterol; 2017 Nov; 70(5):218-222. PubMed ID: 29161790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and safety of venous thromboembolism prophylaxis among hospitalized inflammatory bowel disease patients.
    Ra G; Thanabalan R; Ratneswaran S; Nguyen GC
    J Crohns Colitis; 2013 Nov; 7(10):e479-85. PubMed ID: 23537817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant Therapy in Patients with Cirrhosis.
    Intagliata NM; Northup PG
    Semin Thromb Hemost; 2015 Jul; 41(5):514-9. PubMed ID: 26049069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.